Imagene vs FORE Biotherapeutics
Imagene vs FORE Biotherapeutics, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Imagene is on 62/100 and FORE Biotherapeutics on 56/100.
Where each one leads
Imagene
- our overall score: 62/100 against 56/100
- headcount growth: +16.7% against +8.2%
- LinkedIn following: 11,186 against 4,584
FORE Biotherapeutics
- headcount: 56 against 38
- funding raised: $232M against $44.5M
At a glance
| Measure | Imagene | FORE Biotherapeutics |
|---|---|---|
| What it is | AI-powered platform for profiling cancer biomarkers from digitized biopsy images. | Precision oncology company developing cancer therapies guided by proprietary functional genomics. |
| Category | Healthcare, Genomics, Cancer, Personalized | Healthcare, Drug Development, Genomics, Next Generation Sequencing |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2020 | 2011 |
| Headquarters | Tel Aviv, Israel | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Imagene | FORE Biotherapeutics |
|---|---|---|
| Employees | 38 | 56 |
| Headcount growthLast 12 months | +16.7% | +8.2% |
| Total funding | $44.5M | $232M |
| Latest round | Series B | Series D-2 Extension |
| Valuation | Not published | $75.0M |
| LinkedIn followers | 11,186 | 4,584 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Imagene | FORE Biotherapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 56/100 |
| Traction | 54/100 | 58/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 32/100 | 38/100 |
| Quality | 68/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 33/100 | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Imagene | FORE Biotherapeutics |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | CloudFront | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4, Google Tag Manager | Not detected |
Imagene vs FORE Biotherapeutics: common questions
Which is better, Imagene or FORE Biotherapeutics?
On our 0-100 score Imagene rates higher (62/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Imagene and FORE Biotherapeutics compare on the numbers?
Imagene leads on our overall score (62/100 against 56/100), headcount growth (+16.7% against +8.2%), LinkedIn following (11,186 against 4,584). FORE Biotherapeutics leads on headcount (56 against 38), funding raised ($232M against $44.5M).
Read the full Imagene review and pricing or the FORE Biotherapeutics review and pricing. You can also browse other Imagene alternatives we track.